Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a ...
In this study [12] comparing clinical and laboratory features of patients with ssSSc with those of a group of patients with SSc and limited cutaneous involvement (lcSSc), the authors concluded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback